Atlas Trials

Immune Checkpoint Inhibitors and Atherosclerotic Plaque Volume

Clinical trial NCT04430712 · COMPLETED

Trial details

NCT number
NCT04430712
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Non-small Cell Lung Cancer
Start date
2020-08-01
Primary completion
2022-08-12
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.